All Stories

  1. Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort
  2. Multicenter international cohort study of HA20 reveals novel genetic architecture and phenotypic evolution
  3. Global disparities in adrenaline access: A World Allergy Organization call for equity in anaphylaxis care
  4. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
  5. Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
  6. Characterization of ambient air quality and its relationship with respiratory morbidity in typical cities of Northwest China (NWC)
  7. Case Report: Not all recurrent “idiopathic” anaphylaxis is idiopathic
  8. A World Allergy Organization (WAO) manifesto for the worldwide approval of biologic therapies for food allergy
  9. Unmet needs in hereditary angioedema: an international survey of physicians
  10. Defining Clinical Remission in Severe Asthma: Expert Opinion From the Gulf Region Using the Modified Delphi Method
  11. In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar
  12. Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma
  13. Contact Urticaria and Related Conditions: Clinical Review
  14. WAO - ARIA consensus on chronic cough: Executive summary
  15. Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar
  16. Intravenous immunoglobulin therapy: usage patterns and response to treatment in Qatar over ten years
  17. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts
  18. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
  19. Usage prevalence of angioedema patient–reported outcome measures: Results from the UCARE and ACARE PROMUSE study
  20. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice
  21. Etiology of bronchiectasis in Qatar: A retrospective study
  22. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
  23. The first case report of complement component 7 deficiency in Qatar and a 10-year follow-up
  24. Expert opinion on management of moderate-to-severe atopic dermatitis in Qatar
  25. Epidemiology of combined immunodeficiencies affecting cellular and humoral immunity– a multicentric retrospective cohort study from the Arabian Peninsula
  26. Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
  27. Fc Epsilon RI–Neuroimmune Interplay in Pruritus Triggered by Particulate Matter in Atopic Dermatitis Patients
  28. Auto-immunoproteomics analysis of COVID-19 ICU patients revealed increased levels of autoantibodies related to the male reproductive system
  29. Uncovering a neurological protein signature for severe COVID-19
  30. A review of patch-test data over the period of eight years in the allergy and immunology department in Qatar
  31. Aeroallergens sensitization pattern in atopic patients in Qatar: A retrospective study
  32. Case report: Challenges in the diagnosis of Eosinophilic esophagitis
  33. Circulating microRNA signatures in patients with chronic Urticaria
  34. Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: Qatar experience
  35. The Second Qatar Allergy and Immunology Conference: An Editorial
  36. The rate of exacerbations in patients with asthma in Qatar: A retrospective study during 2019-2021
  37. Predictors of Early Death Among Untransplanted Patients with Combined immunodeficiencies affecting cellular and humoral immunity
  38. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity
  39. Predictors of early death risk among untransplanted patients with combined immunodeficiencies affecting cellular and humoral immunity: A multicenter report
  40. Anaphylaxis after prick‐to‐prick skin test to seafood allergy: A rare adverse event
  41. BCG Vaccine–associated Complications in a Large Cohort of Children With Combined Immunodeficiencies Affecting Cellular and Humoral Immunity
  42. Aerobiological monitoring in a desert type ecosystem: Two sampling stations of two cities (2017–2020) in Qatar
  43. Digital tools in allergy and respiratory care
  44. Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international)
  45. Contributions of nurse specialists in the allergy and immunology service and patient care
  46. Do we need aerobiological air monitoring in desert climates? The Qatar experience
  47. Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
  48. Severity and outcome of COVID-19 disease in patients with allergic rhinitis during the pandemic in Qatar – A preliminary report
  49. Sulphamethoxazole-trimethoprim induced fixed drug eruption in a patient with Chronic Granulomatous Disease
  50. Aspirin challenge and desensitization in patients with suspected AERD in Qatar
  51. Circulatory EVs as a predictor of chronic urticarial activity
  52. First allergy conference in Qatar: Let's explore allergy with a new lens
  53. Real-world experience of the clinical effectiveness of omalizumab use in Qatar – a study protocol
  54. SCIG administration: A promising and patient convenient alternative for those receiving long-term IVIG
  55. Correlation between skin test results and historical manifestations in patients with suspected lidocaine hypersensitivity
  56. First volumetric records of airborne Cladosporium and Alternaria spores in the atmosphere of Al Khor (northern Qatar): a preliminary survey
  57. Untargeted Metabolomics Profiling Reveals Perturbations in Arginine-NO Metabolism in Middle Eastern Patients with Coronary Heart Disease
  58. Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study
  59. Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion
  60. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19
  61. The correlation between middle schoolchildren allergic symptoms and airborne particle season
  62. Viral exanthem following influenza vaccine
  63. A Retrospective Study of Non-Communicable Diseases amongst Blue-Collar Migrant Workers in Qatar
  64. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
  65. Auto-Immunoproteomics Analysis of COVID-19 ICU Patients Revealed Increased Levels of Autoantibodies Related to Male Reproductive System
  66. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
  67. Association of endometriosis with interstitial cystitis in chronic pelvic pain syndrome: Short narrative on prevalence, diagnostic limitations, and clinical implications
  68. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
  69. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19
  70. Abstract 13039: Putative Protective Effects Of Caffeine And Its Metabolites On Coronary Heart Disease In The Middle East
  71. Abstract 13041: Differences In Systemic Fatty Acids Between Coronary Heart Disease Patients And Controls From The Middle East Favors Inflammation
  72. Primary immunodeficiency and the microbiome
  73. In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection
  74. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity
  75. METABOLOMICS REVEALS PERTURBATIONS IN ARGININE-NO METABOLISM, PURINE BIOSYNTHESIS AND CELLULAR ENERGY CHARGE IN PATIENTS WITH CORONARY HEART DISEASE
  76. REPRODUCTIBILITY OF A METABOLITE RISK SCORE TO PREDICT CORONARY HEART DISEASE IN A MIDDLE EASTERN POPULATION
  77. Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort
  78. Robust prognostic signatures derived from proteomic panel profiling of plasma from patients with severe COVID-19 complications
  79. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits
  80. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
  81. A founder RAB27A variant causes Griscelli syndrome type 2 with phenotypic heterogeneity in Qatari families
  82. The association between airborne pollen monitoring and sensitization in the hot desert climate
  83. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
  84. Immunogenetics of Celiac Disease: A Focus on Arab Countries
  85. The Association Between Airborne Pollen Monitoring and Sensitization in the Hot Desert Climate
  86. Etiology and outcome of hemoptysis in Qatar, a high-resource country with a large expatriate population: A retrospective study
  87. A Novel STAT3 Mutation in a Qatari Patient With Hyper-IgE Syndrome
  88. Anaphylaxis triggers in a large tertiary care hospital in Qatar: a retrospective study
  89. Delayed clavulanic acid–induced anaphylaxis in a patient undergoing bariatric surgery
  90. Complex Regional Pain Syndrome Type I Following Tetanus Toxoid Injection
  91. Two cases of food-dependent exercise-induced anaphylaxis with different culprit foods
  92. Renal allograft tuberculosis with infected lymphocele transmitted from the donor
  93. Primary Cutaneous Vasculitis Masquerading as Drug Induced following Aspirin Desensitization
  94. Two Cases of Recurrent Episodes of Angio Edema Without Urticaria or Pruritus
  95. Prevalence of Pharmacogenetic Risk Alleles in a Consanguineous Middle Eastern Population.